Search
for

    Sort by

    Research 421–450 of 1000+

    1. The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model Biology direct · 2010 · 50 citations
    2. Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial British Journal of Cancer · 2009 · 49 citations
    3. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia Food and chemical toxicology · 2012 · 44 citations
    4. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase Scientific Reports · 2016 · 43 citations
    5. Male pattern baldness and the risk of prostate cancer Annals of Oncology · 2011 · 38 citations
    6. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    7. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2004 · 33 citations
    8. Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study BJUI · 2015 · 31 citations
    9. Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer Endocrine Related Cancer · 2010 · 30 citations
    10. Characteristics of flutamide action on prostatic and testicular functions in the rat Journal of Steroid Biochemistry · 1988 · 30 citations
    11. Male pattern baldness and prostate cancer risk in a population-based case–control study Cancer epidemiology · 2010 · 29 citations
    12. Androgenetic alopecia as an early marker of benign prostatic hyperplasia Journal of The American Academy of Dermatology · 2011 · 28 citations
    13. Risks and side effects in the medical management of benign prostatic hyperplasia Prostate International · 2023 · 26 citations
    14. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    15. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations
    16. Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male Journal of the American Geriatrics Society · 1984 · 23 citations
    17. Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia Urologia internationalis · 1998 · 21 citations
    18. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review Prostate Cancer and Prostatic Diseases · 2021 · 21 citations
    19. Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men Cancer Epidemiology, Biomarkers & Prevention · 2013 · 21 citations
    20. Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia The Journal of Urology · 2010 · 20 citations
    21. The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A Scientific Reports · 2020 · 20 citations
    22. Corn silk extract improves benign prostatic hyperplasia in experimental rat model Nutrition Research and Practice · 2017 · 20 citations
    23. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    24. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    25. Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study American Journal of Epidemiology · 2016 · 17 citations
    26. The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor Tumor Biology · 2021 · 16 citations
    27. Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia Pharmaceutical biology · 2019 · 16 citations
    28. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? Journal of Obstetrics and Gynaecology Research · 2007 · 16 citations
    29. Role of 5 alpha-reductase inhibitors in the management of prostate cancer Clinical interventions in aging · 2006 · 15 citations
    30. Finasteride for prostatic disease: an updated and comprehensive review Expert opinion on drug metabolism & toxicology · 2008 · 14 citations